ACM
ADAR1 Capital Management Portfolio holdings
AUM
$616M
This Quarter Return
+4.74%
1 Year Return
+26.77%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$485M
AUM Growth
+$485M
(-19%)
Cap. Flow
-$74.8M
Cap. Flow
% of AUM
-15.41%
Top 10 Holdings %
Top 10 Hldgs %
49.77%
Holding
309
New
41
Increased
54
Reduced
66
Closed
104
Top Buys
| 1 |
Inhibikase Therapeutics
IKT
|
$16.6M |
| 2 |
Zai Lab
ZLAB
|
$13.4M |
| 3 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
$10.1M |
| 4 |
ABVX
Abivax
ABVX
|
$7.26M |
| 5 |
AVR
Anteris Technologies Global Corp. Common Stock
AVR
|
$5.88M |
Top Sells
| 1 |
Royalty Pharma
RPRX
|
$26.7M |
| 2 |
Cytokinetics
CYTK
|
$23.4M |
| 3 |
BridgeBio Pharma
BBIO
|
$21.1M |
| 4 |
Ascendis Pharma
ASND
|
$12.4M |
| 5 |
Immunovant
IMVT
|
$8.53M |
Sector Composition
| 1 | Healthcare | 80.2% |
| 2 | Financials | 3.47% |
| 3 | Communication Services | 1.36% |
| 4 | Utilities | 0.04% |
| 5 | Energy | 0.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Fulcrum Therapeutics
FULC
$351M
| $922K | 0.18% |
196,248
+140,446
| +252% | +$660K |
|
77
Danaher
DHR
$147B
| $918K | 0.18% |
+4,000
| New | +$918K |
|
78
Denali Therapeutics
DNLI
$2.23B
| $914K | 0.18% |
44,826
-57,000
| -56% | -$1.16M |
|
79
Scholar Rock
SRRK
$3.14B
| $843K | 0.17% |
19,505
+7,505
| +63% | +$324K |
|
|
ANSC
80
Agriculture & Natural Solutions Acquisition Corp
ANSC
$471M
| $843K | 0.17% |
80,362
| – | – |
|
81
Spero Therapeutics
SPRO
$116M
| $825K | 0.16% |
801,277
+57,818
| +8% | +$59.6K |
|
82
Keen Vision Acquisition Corporation Units
KVACU
| $824K | 0.16% |
75,000
| – | – |
|
83
Astria Therapeutics
ATXS
$349M
| $813K | 0.16% |
90,984
-2,300
| -2% | -$20.6K |
|
84
Capricor Therapeutics
CAPR
$287M
| $774K | 0.15% |
56,120
+31,813
| +131% | +$439K |
|
85
Neumora Therapeutics
NMRA
$280M
| $727K | 0.15% |
+68,608
| New | +$727K |
|
86
Voyager Therapeutics
VYGR
$186M
| $719K | 0.14% |
126,792
+86,158
| +212% | +$489K |
|
|
BIOA
87
BioAge Labs, Inc. Common Stock
BIOA
$177M
| $712K | 0.14% |
+123,037
| New | +$712K |
|
88
Alector
ALEC
$238M
| $696K | 0.14% |
368,330
-60,472
| -14% | -$114K |
|
89
Alnylam Pharmaceuticals
ALNY
$58.5B
| $682K | 0.14% |
+2,900
| New | +$682K |
|
90
Indivior
INDV
$3.03B
| $672K | 0.13% |
54,057
| – | – |
|
91
Day One Biopharmaceuticals
DAWN
$769M
| $672K | 0.13% |
53,023
-88
| -0.2% | -$1.12K |
|
92
Cidara Therapeutics
CDTX
$1.66B
| $670K | 0.13% |
+24,938
| New | +$670K |
|
93
Kiora Pharmaceuticals
KPRX
$9.55M
| $661K | 0.13% |
200,221
+3,670
| +2% | +$12.1K |
|
94
Protara Therapeutics
TARA
$120M
| $648K | 0.13% |
+122,690
| New | +$648K |
|
95
Instil Bio
TIL
$182M
| $605K | 0.12% |
31,708
+8,001
| +34% | +$153K |
|
96
Organon & Co
OGN
$2.45B
| $600K | 0.12% |
40,200
+37,100
| +1,197% | +$554K |
|
97
Solid Biosciences
SLDB
$427M
| $596K | 0.12% |
148,903
-996,689
| -87% | -$3.99M |
|
|
ONC
98
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $549K | 0.11% |
2,974
+1,996
| +204% | +$369K |
|
99
WisdomTree Floating Rate Treasury Fund
USFR
$18.8B
| $503K | 0.1% |
10,000
| – | – |
|
100
Viridian Therapeutics
VRDN
$1.5B
| $498K | 0.1% |
26,000
+16,794
| +182% | +$322K |
|